How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Medical Device Testing, Inspection, and Certification Market
- By Device Type: Diagnostic Imaging Devices, Surgical Instruments, Cardiovascular Devices, Orthopedic Devices, In Vitro Diagnostic Devices
- By Testing Type: Electrical Safety Testing, Biocompatibility Testing, Performance Testing, Sterilization Validation, Software Validation
- By Inspection Type: Visual Inspection, Dimensional Inspection, Functional Inspection, Packaging Inspection
- By Certification Standard: ISO 13485 Certification, FDA 510(k) Clearance, CE Marking, IEC 60601 Compliance, ISO 14971 Risk Management
- By End-user: Medical Device Manufacturers, Contract Research Organizations (CROs), Regulatory Bodies, Healthcare Providers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Diagnostic Imaging Devices leads By Device Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 300 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.182 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.190 →
Full report · locked preview
Everything inside the Medical Device Testing, Inspection, and Certification Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Device Type 5
Testing Type 5
Inspection Type 4
Certification Standard 5
End-user 4
Companies profiled
SGS SA
Bureau Veritas
Intertek Group plc
TÜV SÜD
UL LLC
Eurofins Scientific
TÜV Rheinland
DNV GL
NSF International
CSA Group
Applus+
Element Materials Technology
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →SGS SA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Bureau Veritas
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Intertek Group plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →TÜV SÜD
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →UL LLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Eurofins Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →TÜV Rheinland
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →DNV GL
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →NSF International
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →CSA Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Applus+
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Element Materials Technology
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →DEKRA SE
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →CIRS Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →MedCert GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$10,216M by 2033 · 10.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Diagnostic Imaging Devices49.0
- Surgical Instruments21.2
- Cardiovascular Devices7.7
- Orthopedic Devices10.7
- In Vitro Diagnostic Devices11.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,502M → $3,437M · 10.9%
Europe$1,047M → $2,355M · 10.7%
Asia Pacific$955.8M → $2,257M · 11.3%
Latin America$591.7M → $1,192M · 9.2%
Middle East and Africa$455.1M → $1,021M · 10.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.602026
10.592027
10.612028
10.612029
10.642030
10.642031
10.652032
10.672033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- SGS SA12.5
- Bureau Veritas13.7
- Intertek Group plc14.3
- TÜV SÜD16.3
- UL LLC7.4
- Eurofins Scientific7.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Device Type23.5%
Testing Type28.1%
Inspection Type8.2%
Certification Standard13.7%
End-user26.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.5
- Europe22.9
- Asia Pacific22.0
- Latin America11.6
- Middle East and Africa10.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| SGS SA | 74 | 82 | 87 | 95 | 95 | 75 | 85 |
| Bureau Veritas | 85 | 93 | 85 | 88 | 79 | 87 | 86 |
| Intertek Group plc | 67 | 77 | 85 | 84 | 80 | 84 | 80 |
| TÜV SÜD | 58 | 59 | 67 | 67 | 77 | 79 | 68 |
| UL LLC | 75 | 72 | 53 | 55 | 59 | 67 | 64 |
| Eurofins Scientific | 62 | 71 | 67 | 56 | 60 | 68 | 64 |
| TÜV Rheinland | 48 | 56 | 56 | 62 | 62 | 52 | 56 |
| DNV GL | 57 | 39 | 44 | 48 | 56 | 57 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- SGS SA
- Bureau Veritas
- Intertek Group plc
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| SGS SA | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Bureau Veritas | ✓ | ✓ | ✓ | ◐ | ◐ | ◐ |
| Intertek Group plc | − | ◐ | ✓ | ◐ | ◐ | ✓ |
| TÜV SÜD | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| UL LLC | ✓ | ◐ | − | ◐ | − | ◐ |
| Eurofins Scientific | ◐ | ✓ | ✓ | − | − | ✓ |
| TÜV Rheinland | ◐ | − | − | ◐ | ◐ | − |
| DNV GL | − | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Bureau Veritas86
2SGS SA85
3Intertek Group plc80
4TÜV SÜD68
5UL LLC64
6Eurofins Scientific64
7TÜV Rheinland56
8DNV GL50
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
SGS SABureau VeritasIntertek Group plc
Challenger1
Strong scale, closing on the leaders.
TÜV SÜD
Contender2
Focused players with pockets of strength.
UL LLCEurofins Scientific
Niche2
Specialists in a single segment or region.
TÜV RheinlandDNV GL
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Device Type in North America, then scale across Medical Device Testing, Inspection, and Certification Market — a $350M beachhead inside a $5.85B market.
Beachhead (SOM)$350Mobtainable near-term
Serviceable (SAM)$2.13Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Diagnostic Imaging Devices
Best fit — highest urgency & budget in Device Type.
Economic buyer80 fit
Surgical Instruments
Strong fit — clear ROI and a fast path to value.
End user67 fit
Cardiovascular Devices
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Device Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Testing Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Inspection Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel27%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Device Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Medical Device Testing, Inspection, and Certification Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified23%
Evaluation13%
Closed-won5%
$10.6KCAC
$49KLTV
4.6:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Medical Device Testing, Inspection, and Certification Market is a high-growth opportunity — $12.4B by 2033, compounding at 11.5%.
TAM · 2025$5.19Btoday
TAM · 2033$12.4Bforecast
CAGR11.5%2027–2033
Cumulative$75.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$12.4BTotal addressable market
SAM$4.96BServiceable available market
SOM$848MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.5% CAGR
Demand compounds through 2033, outpacing GDP across Device Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Device Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$12.4BLarge & growingTAM by 2033 at 11.5% CAGR
$4.96BServiceable nowreachable with today’s model
$848MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$9.69BBear7.5% CAGR
$12.4BBase11.5% CAGR
$15.9BBull15.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Testing Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Medical Device Testing, Inspection, and Certification Market — a $7.91B market by 2033. Plan: grow share from 6.9% to 15.2%.
Market size · 2033$7.91Btotal addressable
Market CAGR7.1%2027–2033
Target share15.2%from 6.9% today
Revenue ambition$1.20Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.9% | 15.2% | At risk |
| Revenue | $560M | $1.20B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 30.2% | 39.7% | Behind |
| Customer retention | 88.4% | 93.1% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Device Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Testing Type capability
A defensible second engine — invest in Testing Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Device Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Testing Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $162M capacity & capability investment
- Greenlight bolt-on M&A in Testing Type
- Authorise North America expansion plan
- Fund R&D program for Device Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Medical Device Testing, Inspection, and Certification Market conversation — a $2.49B market you can size, segment and defend in minutes.
Market size · 2033$2.49Btotal opportunity
Growth7.6%CAGR to 2033
Addressable buyers1,279+accounts in scope
Typical ROI7.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Device Type
Goal Grow share in Device Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.3×return on cost, year one
< 2 mopayback period
$66K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
SGS SABureau VeritasIntertek Group plcTÜV SÜDUL LLCEurofins ScientificTÜV RheinlandDNV GL+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Medical Device Testing, Inspection, and Certification Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Medical Device Testing, Inspection, and Certification Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Medical Device Testing and Certification Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportMedical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportMedical Device Surface Modification Technology Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportMedical Device Support Arms Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportMedical Device Structural Parts Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportMedical Device Sterilization Services Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportMedical Device Sterilization Packaging Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportMedical Device Sterilization and Microbiology Testing Service Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportMedical Device Sterilization and Microbiology Testing Market
Market size, share, segmentation and regional forecast.
$493M market · 2025 base year
View reportMedical Device Sterile Packaging Market
Market size, share, segmentation and regional forecast.
$845M market · 2025 base year
View reportMedical Device Stability Testing Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportMedical Device Spring Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.